References
1. Zhang D, Dong Y, Li Y, Chen J, Wang J, Hou L. Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017; 2017:4191670. doi:10.1155/2017/4191670
2. Muresanu, Dafin F., et al. ”Cerebrolysin and Recovery After Stroke (CARS) A randomized, placebo-controlled, double-blind, multicenter trial.” Stroke 47.1 (2016): 151-159.
3. Ziganshina LE, Abakumova T, Vernay L. Cerebrolysin for acute ischemic stroke. Cochrane Database Syst Rev . 2017;4(4):CD007026. Published 2017 Apr 21. doi:10.1002/14651858. CD007026.pub5
4. Gharagozli K, Harandi AA, Houshmand S, et al. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. J Med Life . 2017;10(3):153-160.
5. Bornstein NM, Guekht A, Vester J, et al. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci . 2018;39(4):629-640. doi:10.1007/s10072-017-3214-0
6. Guekht A, Vester J, Heiss WD, et al. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurol Sci . 2017;38(10):1761-1769. doi:10.1007/s10072-017-3037-z
7. Mekaj YH, Daci FT, Mekaj AY. New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism. Ther Clin Risk Manag . 2015; 11:1449-1456. Published 2015 Sep 24. doi:10.2147/TCRM.S92222
8. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. PMID: 31504418.
9. Berger C, Stauder A, Xia F, Sommer C, Schwab S (2008) Neuroprotection and glutamate attenuation by acetylsalicylic acid in temporary but not in permanent cerebral ischemia. Exp Neurol 210:543–8. 10.1016/j.expneurol.2007.12.002
10. Wei Z, Chigurupati S, Arumugam TV, Jo DG, Li H, Chan SL. Notch activation enhances the microglia-mediated inflammatory response associated with focal cerebral ischemia. Stroke . 2011;42(9):2589-2594. doi:10.1161/STROKEAHA.111.614834